clinical trial · NCT00643656
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
Air Liquide Santé International·phase4·completed·n = 94
Liver BiopsyKalinox 170 barMix of 50% oxygen and 50% nitrogen
brief summary
A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.
started
Oct 1, 2007
primary completion
Jun 1, 2008
completion
Dec 1, 2008
last updated
Mar 13, 2025
official title
Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol